AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths ...

Nkarta's pipeline updates show steady progress, but no major catalysts have emerged. Read what warrants a cautious outlook on ...

The six-year study focused on cyproheptadine, the active compound in the antihistamine Periactin. Periactin is commonly ...

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...